Deficient alternative complement pathway activation due to factor D deficiency by 2 novel mutations in the complement factor D gene in a family with meningococcal infections

Blood. 2006 Jun 15;107(12):4865-70. doi: 10.1182/blood-2005-07-2820. Epub 2006 Mar 9.

Abstract

The complement system is an essential element in our innate defense against infections with Neisseria meningitidis. We describe 2 cases of meningococcal septic shock, 1 of them fatal, in 2 children of a Turkish family. In the surviving patient, alternative pathway activation was absent and factor D plasma concentrations were undetectable. Concentrations of mannose-binding lectin (MBL), C1q, C4 and C3, factor B, properdin, factor H, and factor I were normal. Mutation analysis of the factor D gene revealed a T638 > G (Val213 > Gly) and a T640 > C (Cys214 > Arg) mutation in the genomic DNA from the patient, both in homozygous form. The consanguineous parents and an unaffected sister had these mutations in heterozygous form. In vitro incubation of factor-D-deficient plasma of the boy with serogroup B N meningitidis showed normal MBL-mediated complement activation but no formation of the alternative pathway C3-convertase C3bBbP, and severely decreased C3bc formation and terminal complement activation. The defect was restored after supplementation with factor D. In conclusion, this is the second report of a factor D gene mutation leading to factor D deficiency in a family with meningococcal disease. This deficiency abolishes alternative-pathway dependent complement activation by N meningitidis, and leads to an increased susceptibility to invasive meningococcal disease.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Amino Acid Substitution* / immunology
  • Complement C1q / analysis
  • Complement C1q / genetics
  • Complement C1q / immunology
  • Complement C3-C5 Convertases / analysis
  • Complement C3-C5 Convertases / genetics
  • Complement C3-C5 Convertases / immunology
  • Complement Factor B / genetics
  • Complement Factor B / immunology
  • Complement Factor D / analysis
  • Complement Factor D / deficiency*
  • Complement Factor D / therapeutic use
  • Complement Pathway, Alternative / genetics*
  • Complement Pathway, Alternative / immunology
  • DNA Mutational Analysis
  • Female
  • Genetic Diseases, Inborn / blood
  • Genetic Diseases, Inborn / drug therapy
  • Genetic Diseases, Inborn / genetics
  • Genetic Diseases, Inborn / immunology
  • Genetic Predisposition to Disease
  • Homozygote
  • Humans
  • Infant
  • Male
  • Meningococcal Infections / blood
  • Meningococcal Infections / drug therapy
  • Meningococcal Infections / genetics*
  • Meningococcal Infections / immunology
  • Neisseria meningitidis / immunology
  • Point Mutation* / immunology
  • Shock, Septic / blood
  • Shock, Septic / genetics*
  • Shock, Septic / immunology

Substances

  • Complement C1q
  • Complement C3-C5 Convertases
  • Complement Factor D
  • Complement Factor B